Top Markets
#1 Helium Helium +52.41%
#2 Seeker Seeker +48.95%
#3 Pons Pons +35.30%
#4 UnifAI Network UnifAI Network +28.93%
#5 Tensor Tensor +24.44%
#6 Zylo Ecosystem Zylo Ecosystem +19.85%
#7 TENDIES TENDIES +18.99%
#8 Bounce Bounce +15.82%
#9 Songbird Songbird +15.73%
#10 DAPPOS DAPPOS +14.99%
Coin of the day
Helium Helium
設定
言語
日本
通貨
USD
テーマ
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
株式のランク #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
株価
$14.66
最終同期: 2026-08-28
時価総額
$839.37M
変化（1日）
-2.67%
変化（1年）
557.32%
国
US
取引 Climb Bio, Inc. (CLYM)

カテゴリー

Healthcare
Climb Bio, Inc.（CLYM）のEPS
2026 時点のEPS TTM: 0
Climb Bio, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Climb Bio, Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH